Previous studies have found ATF5 is upregulated in a wide variety of cancers, and have linked ATF5 expression to a malignant phenotype, citing resistance to apoptosis, increased invasive capacity, and treatment resistance [20, 51–53]. This evidence concerns the gene ATF5 and cancer.